Overall, Rush reported a surplus of $132.45 million for 2014, up 19.3 percent from $111 million for the previous fiscal year. Total operating revenue was approximately $1.97 billion for the fiscal year ended June 30, up 7.2 percent from about $1.84 billion from 2013. The rise in revenue was partly driven by a 0.5 percent year-over-year increase in admissions, an additional $48.5 million in Medicaid revenue from the Enhanced Illinois Hospital Assessment Program and a 10.8 percent,or $21.9 million, increase in total patient service revenue from physician practice plans in FY 2014, among other factors. Overall operating EBIDA, however, decreased by 2.7 percent in 2014 to $243.9 million.
Total operating expenses also increased by 7.1 percent, from $1.76 billion in 2013 to $1.89 billion in 2014. A 5.6 percent, or $52.5 million, increase in salaries, wages and employee benefits, and a 13.3 percent, $81.3 million, rise in supplies, utilizes and other expenses contributed to the higher expenses. Additionally, Rush reported a 12.4 percent, or $44.3 million, increase in the cost of malpractice and other insurance in FY 2014.
More articles on health system finances:
Fitch upgrades Stanly Health Services’ bond rating to “A”
Moody’s affirms UW Hospital and Clinics’ “Aa3” rating
UPMC operating revenue up 12% in FY 2014
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
